Iovance Biotherapeutics Inc
SWB:2LB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Iovance Biotherapeutics Inc
SWB:2LB
|
US |
|
Uniqa Insurance Group AG
F:UN9
|
AT |
|
B
|
Barratt Developments P L C
SWB:3BA
|
UK |
|
P
|
Pfizer Inc
F:PFE
|
US |
|
Pernod Ricard SA
F:PER0
|
FR |
|
C
|
Compagnie de Saint Gobain SA
SWB:GOB
|
FR |
|
B
|
Berry Global Group Inc
F:BP0
|
US |
|
W
|
Wharf Holdings Ltd
OTC:WARFF
|
HK |
|
E
|
Eastman Chemical Co
XMUN:EAC
|
US |
|
I
|
Impala Platinum Holdings Ltd
XMUN:IPHB
|
ZA |
|
E
|
Ecolab Inc
SWB:ECJ
|
US |
|
Home First Finance Company India Ltd
BSE:543259
|
IN |
|
S
|
Starbucks Corp
F:SRB
|
US |
|
H
|
Henry Schein Inc
XHAM:HS2
|
US |
|
L
|
Logan Energy Corp
OTC:LOECF
|
CA |
|
Toppan Inc
OTC:TOPPY
|
JP |
|
I
|
Interface Inc
F:IF6N
|
US |
|
A
|
Atlanta Braves Holdings Inc
NASDAQ:BATRK
|
US |
|
B
|
Booking Holdings Inc
F:PCE1
|
US |
|
K
|
Kikkoman Corp
XMUN:KIK
|
JP |
|
F
|
Frontline Ltd
F:FRLN
|
BM |
|
Meituan
F:9MD
|
CN |
|
Merdeka Copper Gold Tbk PT
F:B0C
|
ID |
Bankruptcy Probability
Iovance Biotherapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Iovance Biotherapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
3.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
439.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
182B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Iovance Biotherapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Iovance Biotherapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
